Cargando…
Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326677/ http://dx.doi.org/10.1038/bjc.2012.79 |
| _version_ | 1782229546409394176 |
|---|---|
| author | Khan, O A Blann, A D Payne, M J Middleton, M R Protheroe, A S Talbot, D C Taylor, M Han, C Patil, M Harris, A L |
| author_facet | Khan, O A Blann, A D Payne, M J Middleton, M R Protheroe, A S Talbot, D C Taylor, M Han, C Patil, M Harris, A L |
| author_sort | Khan, O A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3326677 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-33266772013-04-10 Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate Khan, O A Blann, A D Payne, M J Middleton, M R Protheroe, A S Talbot, D C Taylor, M Han, C Patil, M Harris, A L Br J Cancer Letter to the Editor Nature Publishing Group 2012-04-10 2012-03-13 /pmc/articles/PMC3326677/ http://dx.doi.org/10.1038/bjc.2012.79 Text en Copyright © 2012 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter to the Editor Khan, O A Blann, A D Payne, M J Middleton, M R Protheroe, A S Talbot, D C Taylor, M Han, C Patil, M Harris, A L Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate |
| title | Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate |
| title_full | Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate |
| title_fullStr | Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate |
| title_full_unstemmed | Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate |
| title_short | Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate |
| title_sort | reply: metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326677/ http://dx.doi.org/10.1038/bjc.2012.79 |
| work_keys_str_mv | AT khanoa replymetronomicchemotherapywithcyclophosphamideanddexamethasoneinpatientswithmetastaticcarcinomaoftheprostate AT blannad replymetronomicchemotherapywithcyclophosphamideanddexamethasoneinpatientswithmetastaticcarcinomaoftheprostate AT paynemj replymetronomicchemotherapywithcyclophosphamideanddexamethasoneinpatientswithmetastaticcarcinomaoftheprostate AT middletonmr replymetronomicchemotherapywithcyclophosphamideanddexamethasoneinpatientswithmetastaticcarcinomaoftheprostate AT protheroeas replymetronomicchemotherapywithcyclophosphamideanddexamethasoneinpatientswithmetastaticcarcinomaoftheprostate AT talbotdc replymetronomicchemotherapywithcyclophosphamideanddexamethasoneinpatientswithmetastaticcarcinomaoftheprostate AT taylorm replymetronomicchemotherapywithcyclophosphamideanddexamethasoneinpatientswithmetastaticcarcinomaoftheprostate AT hanc replymetronomicchemotherapywithcyclophosphamideanddexamethasoneinpatientswithmetastaticcarcinomaoftheprostate AT patilm replymetronomicchemotherapywithcyclophosphamideanddexamethasoneinpatientswithmetastaticcarcinomaoftheprostate AT harrisal replymetronomicchemotherapywithcyclophosphamideanddexamethasoneinpatientswithmetastaticcarcinomaoftheprostate |